Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. on April 4, 2019, covering events occurring on April 3, 2019. The company, incorporated in Delaware, is an emerging growth company. The filing primarily addresses the pricing of a previously announced underwritten public offering of common units and pre-funded units.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate event rather than periodic financial performance data.
Material Changes
The material event reported is the announcement of the pricing for the underwritten public offering of common units and pre-funded units. No comparative financial changes versus prior periods are detailed in this document.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the offering pricing. The filing incorporates a press release (Exhibit 99.1) by reference for further details. No specific guidance, outlook, risks, or contingencies are explicitly described within the body of this 8-K text.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for the specific price per unit and total proceeds of the offering.
- Verify the number of common units and pre-funded units sold in the offering.
- Confirm the identity of the underwriters involved in the public offering.
- Check subsequent filings for the final closing of the offering and use of proceeds.